Search details
1.
Association of opioid use with survival in patients with cancer treated with immune checkpoint inhibitors: it is time for evidence-based behaviors.
Oncologist
; 2024 Apr 30.
Article
in English
| MEDLINE | ID: mdl-38688456
2.
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents.
Oncologist
; 29(1): 75-83, 2024 Jan 05.
Article
in English
| MEDLINE | ID: mdl-37548439
3.
New horizons for platinum-resistant ovarian cancer: insights from the 2023 American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) Annual Meetings.
Int J Gynecol Cancer
; 34(5): 760-772, 2024 May 06.
Article
in English
| MEDLINE | ID: mdl-38101815
4.
Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.
Lancet Oncol
; 24(6): 624-635, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37269843
5.
Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' Targetability.
Oncologist
; 28(11): 944-960, 2023 Nov 02.
Article
in English
| MEDLINE | ID: mdl-37665782
6.
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives.
Curr Opin Oncol
; 35(6): 507-512, 2023 11 01.
Article
in English
| MEDLINE | ID: mdl-37621167
7.
Mechanisms of Endocrine Resistance in Hormone Receptor-Positive Breast Cancer.
Cancer Treat Res
; 188: 219-235, 2023.
Article
in English
| MEDLINE | ID: mdl-38175348
8.
Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go?
Cancer Treat Res
; 188: 343-351, 2023.
Article
in English
| MEDLINE | ID: mdl-38175352
9.
The Global Landscape on the Access to Cancer Medicines for Breast Cancer: The ONCOLLEGE Experience.
Cancer Treat Res
; 188: 353-368, 2023.
Article
in English
| MEDLINE | ID: mdl-38175353
10.
Screening Programs for Breast Cancer: Toward Individualized, Risk-Adapted Strategies of Early Detection.
Cancer Treat Res
; 188: 63-88, 2023.
Article
in English
| MEDLINE | ID: mdl-38175342
11.
Essential medicines list in national cancer control plans: a secondary analysis from a global study.
Lancet Oncol
; 23(3): e144-154, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35240089
12.
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer.
Curr Opin Oncol
; 34(6): 595-605, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-36083118
13.
Postneoadjuvant treatment for triple-negative breast cancer.
Curr Opin Oncol
; 34(6): 623-634, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-35993306
14.
Challenging cases in high-risk prostate cancer patients treated with Retzius-sparing robot-assisted radical prostatectomy.
World J Urol
; 40(8): 1993-1999, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35771257
15.
National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis.
Lancet Oncol
; 22(11): 1632-1642, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34653370
16.
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
Lancet Oncol
; 22(10): 1367-1377, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34560006
17.
Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors.
Int J Cancer
; 149(7): 1455-1462, 2021 10 01.
Article
in English
| MEDLINE | ID: mdl-34124786
18.
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Lancet
; 395(10224): 591-603, 2020 02 22.
Article
in English
| MEDLINE | ID: mdl-32007142
19.
Uro-oncologic patient management during the COVID-19 pandemic: survey findings from an Italian oncologic hub.
Future Oncol
; 17(27): 3615-3625, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34278823
20.
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey.
Support Care Cancer
; 29(12): 7845-7854, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34176017